← Open Payments lookup

OLUWATOSIN BALOGUN: Open Payments

NPI 1205424694 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,561 in 45 payments from 12 companies in 2025. Trend: 2023 $400 · 2024 $1,007 · 2025 $1,561

Food & beverage: $1,561
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$412
GENZYME CORPORATION8$390
GlaxoSmithKline, LLC.10$227
Takeda Pharmaceuticals U.S.A., Inc.8$164
Organon LLC2$107
ARS Pharmaceuticals Operations, Inc.3$66
Novartis Pharmaceuticals Corporation3$54
Regeneron Healthcare Solutions, Inc.2$50
CSL Behring1$34
Optinose US, Inc.1$24

Products named: DUPIXENT, NUCALA, TAKHZYRO, WAYRILZ, TEZSPIRE, BREZTRI, FASENRA, NEXPLANON.

Industry payments across TX — which companies pay providers there.